# Andrew H. Ko

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/andrew-h-ko/

## Facts

| Field | Value |
| --- | --- |
| Citations | 17,665 |
| Field | Pancreatic and Hepatic Oncology Research |
| h-index | 49 |
| i10-index | 109 |
| Last Known Institution | University of California, San Francisco |
| OpenAlex ID | https://openalex.org/A5070411005 |
| ORCID iD | https://orcid.org/0000-0001-8196-7907 |
| Works | 302 |

## Researcher papers

- [Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer](https://scholariq.org/papers/adjuvant-nivolumab-in-resected-esophageal-or-gastroesophageal-junction-cancer/)
- [Pancreatic Adenocarcinoma, Version 2.2014](https://scholariq.org/papers/pancreatic-adenocarcinoma-version-2-2014/)
- [Pancreatic Adenocarcinoma, Version 2.2012](https://scholariq.org/papers/pancreatic-adenocarcinoma-version-2-2012/)
- [Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-Analysis](https://scholariq.org/papers/neoadjuvant-folfirinox-in-patients-with-borderline-resectable-pancreatic-cancer/)

## Researcher topics

- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Cancer Research and Treatments](https://scholariq.org/topics/cancer-research-and-treatments/)

## Researcher university

- [University of California, San Francisco](https://scholariq.org/institutions/university-of-california-san-francisco/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.